About NextGen Biomed
The discovery and development of innovative biologic therapies, along with the optimization of therapeutic development processes, are increasingly recognized as top priorities in the life sciences industry. R&D leaders must ensure that innovative biologics are strategically integrated into the pipeline, supported by the latest technologies & research platforms, early-stage investments, scalable & sustainable manufacturing strategies and a streamlined regulatory path to accelerate their journey from the lab to the patient.
NextGen Biomed is the platform to advance the fields of biologics, vaccines & novel therapeutics approaches, helping to deliver life-saving medicines to patients faster.
We are committed to creating the bridge for interdisciplinary communication through expertly curated sessions and strategic discussions
Unlocking the Complexities of Next Generation Biomedicines
NextGen Biomed covers the latest R&D trends in proteins & antibodies, peptides and oligonucleotides and their therapeutic applications alongside cutting-edge developments in immunotherapies, cell & gene therapies and vaccine development. As these therapeutic modalities evolve and development challenges become more complex, there is an increasing need for a more nuanced understanding of their mechanisms, optimisation strategies, and scalability to drive improved outcomes.
We unite R&D groups in a collaborative environment that fosters partnerships and strengthens interdisciplinary connections across diverse teams.
Download the Brand at a Glance
Uniting biopharma, research and healthcare experts from around the globe through in-person and digital touchpoints